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Yeast telomeres comprise irregular TG1-3 DNA re-
peats bound by the general transcription factor
Rap1. Rif1 and Rif2, along with Rap1, form the telo-
some, a protective cap that inhibits telomerase,
counteracts SIR-mediated transcriptional silencing,
and prevents inadvertent recognition of telomeres
as DNA double-strand breaks. We provide a molecu-
lar, biochemical, and functional dissection of the pro-
tein backbone at the core of the yeast telosome. The
X-ray structures of Rif1 and Rif2 bound to the Rap1
C-terminal domain and that of the Rif1 C terminus
are presented. Both Rif1 and Rif2 have separable
and independent Rap1-binding epitopes, allowing
Rap1 binding over large distances (42–110 A˚). We
identify tetramerization (Rif1) and polymerization
(Rif2) modules that, in conjunction with the long-
range binding, give rise to a higher-order architecture
that interlinks Rap1 units. This molecular Velcro
relies on Rif1 and Rif2 to recruit and stabilize Rap1
on telomeric arrays and is required for telomere
homeostasis in vivo.
INTRODUCTION
The Saccharomyces cerevisiae repressor-activator protein 1
(Rap1) serves as a general transcriptional activator at about 300
genomic loci (Lieb et al., 2001; Shore and Nasmyth, 1987). At the
two HM silent mating type loci, Rap1 acts as a repressor of gene
expression (gene silencing). Telomere-bound Rap1 is required
for different aspects of telomere homeostasis, including telomere
length regulation, inhibition of telomere end resection, protection
from telomere fusion, and inhibition of undesired activation of the
DNAdamagecheckpoint (reviewed inWellingerandZakian, 2012).
Budding yeast telomere repeats are, on average, 300 bp
in length, largely double-stranded, and capable of binding1340 Cell 153, 1340–1353, June 6, 2013 ª2013 Elsevier Inc.15–20 Rap1 molecules per telomere (Gilson et al., 1993). The
sequence-specific DNA-binding protein Rap1 recognizes the
double-stranded TG1-3 DNA moiety directly (Longtine et al.,
1989) and recruits the Rap1-interacting factors 1 and 2 (Rif1
and Rif2, respectively). Rif1 and Rif2 associate directly with the
Rap1 C-terminal domain (Rap1RCT) in yeast two-hybrid (Y2H)
experiments (Hardy et al., 1992; Wotton and Shore 1997).
The different protective and regulatory roles of telomeres are
not provided by Rap1 alone but in conjunction with other pro-
teins that assemble a ‘‘capping’’ structure, also referred to as
the telosome (Wright et al., 1992). Themammalian capping com-
plex is known as shelterin (reviewed in de Lange, 2005).
In budding yeast, the protective telomere cap is composed of
Rap1-Rif1-Rif2, Ku70-Ku80, and the Cdc13-Stn1-Ten1 (CST)
complex. The CST complex associates at the telomeric single-
stranded 30 overhang, preventing its degradation during S phase
(Vodenicharov and Wellinger, 2006). The Ku70-Ku80 complex is
a ubiquitous DNA end-binding factor that protects telomeres
from resection in nondividing cells (Vodenicharov et al., 2010).
Complexes of Rap1-Rif1-Rif2, being the major protein compo-
nents that bind double-stranded TG1-3 repeats, serve in central
aspects of telomere homeostasis.
The capping structure that forms through Rap1, Rif1, and Rif2
assembly at telomeres is the focus of this study. Wild-type (WT)
telomere length is thought to be maintained by a feedback
mechanism that controls telomerase action through an inhibitory
signal whose strength is proportional to the amount of bound
Rap1, Rif1, and Rif2 molecules (Marcand et al., 1997). Conse-
quently, loss of Rif1 or Rif2 results in elongated telomeres. Rif1
and Rif2 prevent telomeres from inadvertent recognition as a
DNA double-strand break (DSB), thus contributing to telomere
capping. Rif2 and Rap1 inhibit both nuclease access and non-
homologous end-joining (NHEJ) at telomeres (Marcand et al.,
2008), whereas the loss of Rif1 does not affect NHEJ and only
slightly increases single-stranded DNA generation at telomeres
(Marcand et al., 2008; Bonetti et al., 2010). Instead, Rif1 rein-
forces the CST complex, given that Rif1 is required for cell
viability specifically when CST activity is reduced (Anbalagan
et al., 2011). However, both Rif1 and Rif2 carry out
nonoverlapping roles in preventing G2/M checkpoint activation
at telomeric DNA ends that are flanked by only short arrays of
TG1-3 repeats (Ribeyre and Shore, 2012).
In vitro, Rap1 molecules bind TG1-3 repeats in an independent
fashion, and there is no obvious crosstalk between individual
Rap1 units (Williams et al., 2010). No novel property emerges
once multiple Rap1 sites are juxtaposed, as judged by the
absence of cooperative binding (Gilson et al., 1993). Yet, in vivo,
arrays of TG1-3 Rap1-binding sites confer telomere capping
properties once approximately 4–5 (or perhaps even fewer)
Rap1-binding sites are present (Ribeyre and Shore, 2012). It
has been unclear what allows double-stranded arrays of Rap1-
binding sites to act as a protective telomeric cap once a certain
number of Rap1-binding sites are present. Why the proteina-
ceous cap is recruited to telomeres, but not to individual Rap1
sites, is a crucial question.
The focus of our study was to characterize the protein-protein
interaction scaffold underlying the S. cerevisiae telomere-
capping complex comprised of Rap1, Rif1, and Rif2. We set
out to examine how these interactions form a capping structure
on telomeric DNA and how they contribute to telomere homeo-
stasis in vivo.
RESULTS
Rif2 Interacts through Distinct Epitopes with Two
Adjacent Rap1RCT Domains
First, we examined Rif2 and its complex with Rap1. The struc-
tures of Rif2 (residues 66–380) alone (Figure 1A) and full-length
Rif2 (1–395) in complex with the Rap1 C-terminal domain
(Rap1RCT: 672–827) were solved by X-ray crystallography (Fig-
ure 1B) and refined at a 2.9 and 3.3 A˚ resolution, respectively.
In comparing Rif2 in complex with Rap1 and alone, no significant
conformational changes are observed in Rif2. The structure of
Rif2 identifies it as a member of the ATPase family associated
with diverse cellular activities (AAA+) that exist in oligomeric or
monomeric form (Figures S1A and S1B available online). We
find that Rif2 is monomeric in solution (Figure S1F).
The Rif2 AAA+ structure consists of two lobes (Figure 1A), an
a-helical domain composed of six helices (a0 and a6–a10) and
an additional strand-conserved E family (ASCE) domain found
as an insertion between a0 and a6. The defining feature of
AAA+ proteins is the structurally conserved NTPase domain
(ASCE domain), which containsWalker A (or P loop) and Bmotifs
(reviewed in Erzberger and Berger, 2006). Most AAA+ proteins
function by linking ATP-mediated conformational changes within
an oligomeric assembly to specific chemomechanical motions
that direct the translocation or remodeling of target substrates.
However, an increasing number of AAA+ proteins that aremono-
meric and not active as ATPases or do not even bind ATP have
been identified. In the case of Rif2, the ATP-binding site within
its AAA+ domain is degenerate (Figures S1B and S1C), and
isolated Rif2 shows no measurable ATP hydrolysis (data not
shown). We cannot rule out the importance of this site for ligand
binding or posttranslational modification, given that mutations in
the nucleotide-binding groove exhibited mild phenotypes in
telomere length regulation andG2/Mcheckpoint response in vivo
(Figures S1D and S1E). The Rif2 C terminus (371–395, referred toas Rif2CTD) (Figure 1A) does not contain discernible secondary
structure elements and is found to be stabilized by packing
interactions within the Rif2 crystal lattice.
In the Rif2-Rap1 complex structure (Figure 1B), we found that
each Rif2 molecule binds to two different Rap1RCT molecules
through two independent interfaces: the Rif2 AAA+ domain
(Rif2AAA+) and an N-terminal extension peptide comprising resi-
dues 36–48 (subsequently referred to as the Rap1RCT-binding
module [Rif2RBM]). Conversely, one Rap1RCT binds two Rif2 mol-
ecules (Figure 1F). The Rif2AAA+-Rap1 interaction is directed
towards the N-terminal face of Rap1RCT. Rap1 residues F708
and P705 interact with Rif2 residues L79, F342, and V350,
participating in extended hydrophobic interactions (Figure 1C).
A pronounced salt bridge is formed between Rif2 E347 and
Rap1 R747 (Figure 1C). The interfaces between Rap1 H709
with Rif2 T346, as well as those between Rap1 R747 with Rif2
E347 (Figure 1C), are consistent with previousmapping attempts
(Feeser and Wolberger, 2008). An additional minor interface is
provided by Rif2CTD, which we found sandwiched between the
Rif2 a-helical bundle and the ASCE domain (Figures 1B, 1D,
and S2A). Hydrogen bonding interactions were observed
between Rif2 L386, Q382, and A375 and Rap1 Q715, D742,
and R747, respectively (Figure 1D). The second Rap1-binding
interface is formed by Rif2RBM, which attaches as a helix in a
Rap1RCT surface cleft formed by helices a3 through a6 (Figures
1B and 1E). The RBM peptide sequence could be assigned
despite medium resolution and was validated by seleno-
methionine labeling in combination with mutagenesis (Figures
S2B–S2D). Rif2RBM residues L42 and L44 bind to the Rap1
hydrophobic cleft provided by Rap1 residues L736, L755,
L762, and A733 (Figure 1E). Interestingly, the Rif2RBM epitope
and the Rif2AAA+ domain from one Rif2 molecule are unable to
simultaneously engagewith the sameRap1molecule (Figure 1F);
the observed distance between the last visible residue in Rif2RBM
(K48) and the first visible residue of the Rif2AAA+ domain (P61)
comprises more than 60 A˚ in the crystal, whereas the maximally
calculated root mean square (rms) end-to-end distance of the
interjacent 14-residue linker (48–61) is only 42 A˚ (Miller and
Goebel, 1968). Therefore, the Rif2RBM epitope originates from
a second Rif2 molecule in the crystal lattice located 28 A˚
from the nearest Rap1RCT.
A Single Rif2 Molecule Is Able to Bind Two Separate
Rap1 Molecules In trans in Solution
The crystal structure indicated that the RBM and AAA+ inter-
faces of the same Rif2 molecule do not bind to a common
Rap1 molecule, but, rather, they bind to two different Rap1 mol-
ecules. Furthermore, it predicts that Rif2RBM/Rif2AAA+ are able to
autonomously bind Rap1. We used isothermal titration calorim-
etry (ITC) to independently validate the Rap1- and Rif2-binding
mode observed in the crystal (Figures 1G–1I). In solution, a
Rif2 RBM epitope containing residues 30–49 bound Rap1RCT
with an affinity of 30 mM, as measured by ITC (stoichiometry
N = 1.1 ± 0.2) (Figure 1G). A Rif2 construct without the RBM-
epitope, but retaining the AAA+ interface (Rif2 66–395), bound
Rap1RCT with an affinity of 50 mM (N = 1.05 ± 0.02) (Figure 1H).
Thus, the two isolated RBM and AAA+ interfaces have
comparable affinities (Rif2RBM-Rap1RCT, 30 ± 20 mM, versusCell 153, 1340–1353, June 6, 2013 ª2013 Elsevier Inc. 1341
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Figure 1. Crystal Structure of Rif2 and the Full-Length Rif2-Rap1RCT Complex
(A) Cartoon diagram of the Rif2 (66–380) structure and Rif2 domain organization with a corresponding color code.
(B) Cartoon diagram of full-length Rif2 in complex with two Rap1RCT (yellow) bound.
(C–E) Close-up views of the interfaces between Rap1RCT and Rif2AAA+ (C), Rif2CTD (D), and Rif2RBM (E).
(F) trans interactions between Rif2 and Rap1RCT. The cisRif2 molecule (grey shadowed) directly contacting Rap1RCT through its AAA+ domain is unable to donate
the RBM domain bound on the same Rap1RCT because of the >60 A˚ linker requirement (grey dotted line). Instead, that Rif2-RBM domain is donated by a
neighboring trans Rif2 molecule (dark blue/green) with a 28 A˚ connecting path linking Rif2 P61 and K48, shown as a blue dotted line.
(G–I) Isothermal titration calorimetry (ITC) of Rap1RCT and Rif2RBM (Rif230-49) (G), Rif2AAA+ (H), and full-length Rif2 (I). Kd and N values are the mean of several
experiments.
See also Figures S1 and S2.
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Rif2AAA+-Rap1RCT, 50 ± 30 mM) despite the fact that the Rif2AAA+-
Rap1RCT interface is considerably larger (Rif2RBM-Rap1RCT,
729 A˚2, versus Rif2AAA+-Rap1RCT, 1280 A˚
2) (Figure 1E versus Fig-
ure 1C–1D). If both interfaces were to bind the same Rap1 mole-
cule, the two dissociation constant (Kd) values would be
expected to potentiate each other, resulting in a significantly
higher overall affinity (by orders of magnitude) (Borsi et al.,
2010). On the other hand, if the two interfaces were to function
independently, no significant change in overall affinity would
be expected. Full-length Rif2, carrying both the RBM and the
AAA+ interfaces, showed a Rap1-binding affinity of 30 mM
(N = 1.0 ± 0.2) (Figure 1I). Given that both Rif2AAA+-Rap1RCT
and Rif2RBM-Rap1RCT-binding reactions have similar affinities
and amplitudes, we interpret the full-length Rif2 titration as a
2(Rap1RCT):2(Rif2 full-length) complex (or multiples thereof)
with Nz 1. This is consistent with the Rif2 RBM and AAA+ inter-
faces binding Rap1 independently of each other in solution, each
contacting a different Rap1 molecule. Thus, a single Rif2 mole-
cule in solution is able to bind one Rap1 molecule through
Rif2AAA+ while holding a second Rap1 in trans through Rif2RBM.
Conversely, it is also true that one Rap1 molecule binds simulta-
neously to two Rif2 molecules in a nonoverlapping fashion
(Figures 1B, 1F, and S2E).
Rif1CTD Serves as a Rap1-Binding and Tetramerization
Module
Next, we turned our attention to Rif1 and examined its mode of
Rap1 binding. Using limited proteolysis, we were able to map
the Rif1 carboxyl-terminal Rap1-binding domain to residues
1,857–1,916 (data not shown), designated as Rif1 carboxyl-
terminal domain (Rif1CTD) (Figure 2A). Subsequently, we crystal-
lized Rif1CTD, determined its structure by ab initio methods, and
obtained a refined model at a 1.94 A˚ resolution (Figure 2A).
Rif1CTD is composed of two antiparallel Rif1 dimers, tetrameriz-
ing along a pseudo-2-fold symmetry axis. Structure-based
sequence alignment revealed that the Rif1CTD domain is
conserved from yeast to humans (Figure S3A). The tetrameriza-
tion interface of the two dimers utilizes four prominent salt
bridges formed by residues R1895 and E1906 from the opposing
helix a4 (Figure 2D). Using multiangle light scattering (MALS), we
confirmed that Rif1CTD is also tetrameric in solution, the
measured molecular weight (MW) being 93 kDa for a Rif1CTD-
containing fragment (1,709–1,916) and 23.5 kDa for the mono-
mer (Figure S3B). Intradimer packing proceeds in canonical
knobs-into-holes fashion, largely driven by internal hydrophobic
interactions (L1883, I1886, L1894, L1898, and L1905) and sur-
face salt bridges (K1867 to E1897 and R1876 to D1882) (Figures
2B and 2C). We find that this interface is important for tetrameri-
zation, given that an arginine mutation of residue L1905, which is
highly conserved across the eukaryotic orthologs (Figure S3A),
led to a significant reduction in apparent molecular weight in
size-exclusion chromatography (Figure S3B). The observed
molecular weight of Rif1 L1905R (residues 1,709–1,916) by
MALS was 35 ± 2 kDa (Figure S3B), indicating an equilibrium
between a monomer (23.5 kDa) and a dimer (47 kDa) with no
apparent sign of tetramerization.
In a previously published Y2H assay, a larger Rif1 construct
(1,614–1,916) carrying the Rif1CTD domain was reported tobind Rap1RCT (Hardy et al., 1992). Mutation of E1906K within
this construct showed 4-fold reduced binding to Rap1RCT.
However, the diminished interaction due to the E1906Kmutation
in Rif1 was rescued by a compensatory D727Amutation in Rap1
(identified as the rap1-12 allele) (Hardy et al., 1992). On the basis
of the Rif1CTD structure from this study, E1906 is located at the
Rif1CTD interdimer interface (Figure 2D) where it is only partially
solvent accessible. Additionally, we found that mutation of
residues L1905R (Figure 2B) and R1895E (Figure 2D), located
at the intradimer and interdimer interfaces, respectively, showed
reduced Rap1 binding in a Y2H assay (Figure 2E). Although the
Rap1-binding defect for L1905R was pronounced, the defect
seen with Rif1 R1895E was slightly less severe. The structure
demonstrates that L1905 is fully buried in the interface and,
thereby, unlikely to bind Rap1 directly (Figure 2B), although its
mutation to arginine interferes with tetramerization, as judged
by size-exclusion chromatography (Figure S3B). Therefore, the
defect in Rap1 binding seen in the Rif1CTD mutants is most likely
an indirect consequence of tetramerization, possibly because
tetramerization is required for assembling the Rap1-binding
interface.
A Short Rif1 Peptide Provides a Second Rap1 Binding
Site
In our Y2H mutational scanning analysis, we noticed that
mutating the Rif1CTD domain in a construct spanning residues
1,709–1,916 (Figure 2A) did not lead to the complete loss of
Rap1 binding (Figure 2E). Therefore, we examined conserved
Rif1 residues outside the Rif1CTD domain in search of additional,
previously uncharacterized Rap1-binding sites. Sequence align-
ments of Rif1 orthologs from diverse yeast species revealed a
conserved 20-amino-acid motif (1,752–1,772) (Figure 2F). Muta-
tion of conserved residues within this motif (I1760R, I1762R, or
I1764R) abolished Rif1-Rap1 binding in Y2H assays (Figure 2G).
ITC experiments using a Rif1 construct including both the
conserved Rif1 1,752–1,772 peptide and the Rif1CTD domain
showed an interaction with Rap1 at a Kd of 20 mM (N =
0.99 ± 0.02) (Figure 2H). Mutating the Rif1CTD still yielded a
detectable ITC interaction with an estimated Kd of 50 mM (Fig-
ures S3C–S3D). However, a fragment without the conserved
peptidemotif (1,766–1,916) only carrying the Rif1CTD domain dis-
played no detectable binding to Rap1 in ITC (Figures S3C–S3D).
The conserved Rif1 region comprises residues 1,752–1,772 and,
hence, appears to be the major Rap1-binding epitope within
Rif1, whereas the Rif1CTD domain serves as a tetramerization
platform and as a secondary, comparably weaker Rap1-binding
site in solution.
Next, we set out to study the molecular details of the Rif1
1,752–1,772 peptide interaction with Rap1RCT. This Rif1 peptide,
which, in analogy to Rif2, was named the Rap1-binding module
(Rif1RBM), cocrystallized with Rap1RCT and allowed structural
analysis of the Rif1RBM-Rap1RCT complex at a 1.6 A˚ resolution
(Figure 2I). In the crystal, we found three Rap1RCT molecules in
the asymmetric unit complexed by three Rif1RBM peptides,
resulting in an overall 1:1 stoichiometry. The electron density of
Rif1 1,760–1,766 was observed for the Rif1RBM peptide in the
structure. Strikingly, the crystal revealed that Rif1RBM binds
Rap1RCT as a linear peptide at a location identical to that foundCell 153, 1340–1353, June 6, 2013 ª2013 Elsevier Inc. 1343
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Figure 2. Crystal Structures of the Rif1CTD Tetramer and the Rif1RBM-Rap1RCT Complex
(A) Cartoon diagram of the Rif1CTD tetramer structure with the two pseudo-2-fold symmetry axes marked by dotted lines. The four protomers are depicted in light
and dark pink and light and dark grey, respectively. The domain structure of S. cerevisiae Rif1 is shown above.
(B–D) Close-up views of the Rif1CTD tetramer. The intradimer interface located between light pink and dark pink protomers is depicted in (B) and (C), and (D)
illustrates the tetramer and interdimer interface located between pink and grey protomers.
(E) Yeast two-hybrid (Y2H) mapping with Rif1 (1,709–1,916) and Rap1 (672–827) fusion proteins. Mutations in the intradimer (L1905R) and interdimer and tetramer
(R1895E) interface weaken the Rif1-Rap1 interaction.
(F) Rif1RBM sequence alignment across yeast species. Residues involved in Rap1 binding are indicated by blue dots.
(G) Y2H interactions between the WT Rap1 fragment (672–827) and Rif1 (1,710–1,916) with mutations in the RBM domain (I1764R, I1762R, or I1760R). Below,
interactions of the WT Rif1 fragment with two Rap1 derivatives carrying mutations in the RBM-binding cleft (G760R or A733R).
(H) Isothermal titration calorimetry (ITC) of Rap1RCT and Rif1 (1,709–1,916). The Kd and N values are the mean of several experiments.
(I) Cartoon representation of the Rap1RCT-Rif1RBM complex. The Rif1RBM peptide (cyan) and its interacting residues on Rap1RCT (yellow) are shown as a close-up
view, and the final 2FO-FC electron density of Rif1RBM peptide is contoured at 1s (shown in grey).
See also Figure S3 and Table S2.
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A Figure 3. Rif1 and Rif2 Interlink Rap1 on Te-
lomeric Repeats
(A) Left, on Rap1RCT, the RBM-binding groove
(grey) for Rif1RBM or Rif2RBM and the Rif2AAA+
(green)-binding site are indicated in the secondary
structure topology diagram. Rap1RCT Interaction
residues for Rif2AAA+, Rif1RBM-Rif2RBM, and
Rif1CTD are marked in Figure S4D. Right, Rap1RCT
(yellow)-Rif2AAA+ (green)-Rif1RBM (cyan) complex
with a second Rap1RCT (grey) bound by Rif2RBM
(red) in trans. The position of the Rap1 D727 mu-
tation (magenta), which is rescued by a comple-
mentary Rif1CTD E1906K mutation, is indicated.
(B) Rif1- and Rif2-dependent preference of Rap1
for arrayed over individual Rap1-binding sites.
EMSA analysis of purified Rap1 (80 nM), Rif2
(80 nM), and Rif1 (1,709–1,916) (160 nM) incubated
with 1 nM 32P-labeled telomeric DNA (Tel270) and
20 ng poly(dIdC). Reactions contained sequence-
specific competitor DNAs with one (Tel19), two
(Tel31), or four (Tel80) Rap1-binding sites at 240,
120, and 60 nM, respectively, providing a non-
varying 17-fold excess of total Rap1-binding sites
over Tel270.
(C) Array-specific binding of Rap1 requires Rif1
and Rif2 trans-binding modules. Reactions are the
same as in (B) with Tel19 as a competitor. The
trans-binding-deficient mutants Rif2*RBM/AAA+
(L44R-V45E-E347R) (lanes 2 and 3) and Rif1*RBM
(I1762R-I1764R) (lanes 4 and 5) or a combination
of the two (lanes 6 and 7) were tested against WT
Rif1 and Rif2 (lanes 8 and 9).
See also Figure S4 and Tables S2 and S3.for Rif2RBM (Figures 2I and 1B). Like Rif2RBM, Rif1RBM binds
through extended hydrophobic interactions with Rap1RCT bind-
ing mediated by residues I1760, I1762, I1764, and F1765 (Fig-
ure 2I). Secondary structure prediction and limited proteolysis
experiments (data not shown) suggest that Rif1RBM connects
to the tetrameric Rif1CTD domain through an unstructured linker
(residues 1,773–1,856) (Figure 2A). Because of the presence of
84 residues between the RBM and CTD domains, this linker is
expected to span about 110 A˚. Altogether, these data imply
that a Rif1 tetramer may bind to more than one (most likely
four) Rap1 molecules in solution, in line with the observed
stoichiometry in ITC (Figure 2H) (each Rif1CTD tetramer is ex-
pected to bind four Rap1 molecules, giving rise to an apparent
1:1 stoichiometry).
Interconnecting Rap1-Rif1 and Rap1-Rif2 Complexes
through Overlapping and Nonoverlapping Binding Sites
Our structural studies reveal that the RBM domains of Rif1 and
Rif2, in complex with Rap1RCT, fully overlap structurally and,
thus, are mutually exclusive. Yet, as judged by the structure,
the Rif1RBM and Rif2AAA+ interfaces do not overlap (Figure 3A),
and the Rif2 RBM and AAA+ interfaces most likely engage
two different Rap1 molecules. Furthermore, this is supportedCell 153, 1340–13by published data (Feeser and Wol-
berger, 2008), which can now be ratio-
nalized by our structures; mutation of aRap1 surface residue R747, which we found at the Rif2AAA+
interface (Figure 1C), diminished the Rap1-Rif2 interaction by
Y2H without affecting the Rap1-Rif1 interaction. The same
study demonstrated that mutation of the published Rif1CTD-
binding site on Rap1 (Rap1, D727) reduced Rap1-Rif1-binding
in a Y2H assay but retained the Rap1-Rif2 interaction. This indi-
cated that the Rif1CTD-binding site on Rap1 is also nonoverlap-
ping with both the Rif2AAA+ and Rif2RBM or Rif1RBM interaction
sites (Figure 3A). Altogether, these data suggest that three of
the four Rap1-binding interfaces utilized by Rif1 and Rif2 are
nonoverlapping.
Although we did not observe a direct interaction between Rif1
and Rif2 by solution pulldown or Y2H assays (data not shown),
the modular nature of these nonoverlapping binding sites
nonetheless endows Rif1 and Rif2 with the capacity to simulta-
neously bind to a common Rap1 molecule, giving rise to a
Rif1-Rif2-Rap1 ternary complex bridged by Rap1 (Figure 3A).
Rif1 and Rif2 Interconnect Rap1 Units on DNA Arrays
Next, we examined if such an interconnection of neighboring
complexes may be facilitated on DNA arrays in vitro, where
cognate, juxtaposed Rap1-binding sites are expected to
generate high local Rap1 concentrations, potentially leading to53, June 6, 2013 ª2013 Elsevier Inc. 1345
stable higher-order complexes. Rap1 binds to its cognate recog-
nition site in a noncooperative manner (Gilson et al., 1993;
Williams et al., 2010). Binding occurs independently of the occu-
pancy of adjacent sites, and there was no detectable crosstalk
between neighboring Rap1 units on telomeric DNA. We set out
to test whether Rif1 and Rif2 serve to interconnect Rap1 units
on DNA.
In electromobility shift assays (EMSA) we used a 32P-labeled
270 bp telomere DNA fragment (Tel270) carrying 14 predicted
Rap1-binding sites (Gilson et al., 1994; Williams et al., 2010).
When Tel270 was incubated with increasing amounts of Rap1,
we observed characteristic laddering due to stochastic binding
of Rap1 to these 14 sites (Figure S4A). Then, we loaded Rap1
onto Tel270 and subsequently challenged the Rap1-Tel270
complex with unlabeled specific competitor DNA. Under these
conditions, no Rap1 displacement from Tel270 was observed
(data not shown). Given the slow dissociation rate of Rap1
from its cognate binding site (koff[1 hr) (Williams et al., 2010)
and its reduced stability after 1 hr (see Figure S4B), we could
not pursue equilibrium-based approaches. Therefore, we exam-
ined the distribution of Rap1 when incubated simultaneously
with labeled Tel270 substrate and unlabeled specific com-
petitors carrying one (Tel19), two (Tel31), or four (Tel80) Rap1-
binding sites (Figure 3B, lanes 3–6). This experimental setup
allows us to measure a kinetic parameter, the association rate
(or ‘‘on’’-rate), of Rap1 to arrays of different sizes. The amounts
of specific competitor DNAwere adjusted such that Tel19, Tel31,
and Tel80 provided an equivalent concentration of 240 nM Rap1
recognition sites per experiment, whilst having one, two, or four
Rap1 sites per competitor duplex, respectively. Rap1 was held
at 80 nM with Tel270 present at 1 nM (equivalent of 14 nM
Rap1-binding sites). All experiments were carried out in the
presence of poly(dIdC), quenching nonspecific DNA interac-
tions. In EMSA, Rap1 now partitioned away from Tel270 towards
the excess of unlabeled substrate. The extent of partitioning was
independent of the number of binding sites per competitor DNA
(Tel19, Tel31, or Tel80) (Figure 3B, compare fully occupied Rap1-
Tel270 in lane 3 with the partially saturated DNA ladders in lanes
4–6), demonstrating that Rap1 exhibits no preference for arrays
over single binding sites, as is expected for noncooperative
Rap1-DNA binding.
Next, we used this assay to investigate whether the addition of
Rif1 and Rif2 may favor Rap1 binding to arrays of binding sites
and whether any such preference might be dependent on the
multivalent Rap1-binding motifs in Rif1 and Rif2. Full-length
Rif2 and Rif1 (1,709–1,916, containing both the Rif1RBM and
the Rif1CTD domains) were now included in the experiment (Fig-
ure 3B, lanes 7–10; note that Rif1 and Rif2 exhibit no Tel270 bind-
ing under the conditions used, lane1). Rap1 partitioning was
assessed between labeled Tel270 (14 nM Rap1 sites) and unla-
beled Tel80 (240 nM Rap1 sites) (Figure 3B, lane 10) in the pres-
ence of 80 nMRif2 and 160 nMRif1. The result showed that Rap1
partitioned between Tel270 (14 sites) and the excess of Tel80
(4 sites) in a manner similar to what was observed with Rap1
alone (Figure 3B, compare lanes 10 and 6), revealing a distinct
ladder on Tel270. Thus, the Tel80 array with four Rap1 sites
effectively competed with Tel270 for binding Rap1 in the pres-
ence of Rif1 and Rif2. However, when partitioning was carried1346 Cell 153, 1340–1353, June 6, 2013 ª2013 Elsevier Inc.out between Tel270 and Tel31 with two Rap1 sites (Figure 3B,
lane 9) or between Tel270 and Tel19 with one Rap1 site (Fig-
ure 3B, lane 8) distinct laddering (Figure 3B, lane 10) disap-
peared. Then, we repeated the experiment with Tel19 at different
time points (10 min and 1 hr), all of which revealed a qualitative
difference for partitioning between Tel270 and Tel19 in the pres-
ence, or absence of Rif1 and Rif2 (Figure S4B). Rather than
competing Rap1 off Tel270, giving rise to free Tel270 DNA and
lower Rap1 occupancy, the Rif1-Rif2-Rap1 complexes remained
bound to Tel270 under these conditions, revealing a broad distri-
bution of higher molecular weight intermediates (see Figure S4C
for detailed explanation). Thus, Tel80 (four sites), Tel31 (two
sites), and Tel19 (one site), showing a decreasing number of
Rap1-binding sites per molecule but providing the same total
number of binding sites per reaction, progressively failed to
sequester Rap1 from Tel270 in the presence of Rif1 and Rif2.
We conclude that Rif1 and Rif2 enable Rap1, in the biologically
relevant time frame of the 90 min generation cycle of dividing
yeast cells, to associate with arrays of cognate recognition
sites preferentially over individual binding sites, a feature not
observed in the absence of Rif1 and Rif2.
The trans-BindingModules in Rif1 andRif2 AreRequired
for Array-Specific Rap1-DNA Interactions
Because Rif1 and Rif2 do not bind DNA in the absence of Rap1 in
our experimental conditions (Figure 3B, lane 1), we went on to
test whether multivalent long-range Rap1-binding interactions
in Rif1 and Rif2 mediate preferential recruitment of Rif1-Rif2-
Rap1 to arrays. We used the same experimental setup as in
Figure 3B, comparing Rap1 partitioning between Tel270 and
Tel19 in the presence of WT Rif1 and Rif2, or various mutants
defective in binding neighboring Rap1 units in trans (Figure 3C).
Our reasoning was that when the Rap1 trans-binding modules of
Rif1 and Rif2 are compromised, preferential binding of Rap1 to
arrays in the presence of Rif1 and Rif2 would be lost. This would
give rise to band-shift patterns similar to those observed for
Rap1 alone. We found that mutation in either the Rif1RBM
(I1762R-I1764R) or the Rif2RBM/AAA+ (E347R-L44R-V45E) motif
resulted in a clear loss of preferential binding to Tel270 (Fig-
ure 3C, compare lane 8 with lanes 2 and 4), as indicated by the
characteristic laddering previously seen for Rap1 in the absence
of Rif1 and Rif2 (Figure 3B, lane 4). The effect observed when
Rif1RBM and Rif2RBM/AAA+ motifs were both mutated was only
slightly more pronounced than when testing one WT and one
mutant version of these proteins in combination (Figure 3C,
compare lane 6 with lanes 2 and 4). Therefore, our data suggest
that the preferential binding of Rap1-Rif1-Rif2 assemblies to ar-
rays in vitro requires the long-range Rap1-binding modules
(Rif1RBM and Rif2RBM/AAA+) identified in solution. This provides
support for the idea that, in Rif1 and Rif2, both Rap1 trans-bind-
ing modules stabilize the protein assembly on arrays of Rap1-
binding sites, consistent with the formation of an interlinked
scaffold.
The Multivalent Rap1-Binding Sites in Rif1 and Rif2
Function at Telomeres In Vivo
Next, we assessed whether the multivalent Rap1-binding motifs
in Rif1 and Rif2 are needed for Rif1- and Rif2-mediated telomere
homeostasis in yeast. As a first step, we examined Rif1 and Rif2
recruitment to native telomeres. Alleles encoding Rif1 (I1762R-
I1764R, conserved among yeast species) (Figure 2F), Rif1
(L1905R, highly conserved across all eukaryotes) (Figure S3A),
Rif2 (E347R), and Rif2 (L44R-V45E) mutant proteins (referred to
hereafter as Rif1*RBM, Rif1*CTD, Rif2*AAA+, and Rif2*RBM [Fig-
ure S5A], respectively) were constructed with a C-terminal Myc
tag at their endogenous locus for chromatin immunoprecipita-
tion (ChIP). Western blot analysis indicated that all four mutants
are expressed at levels identical to their WT counterparts (Fig-
ures S5B–S5C). ChIP at telomeres on chromosomes VI-R and
XV-L showed a 110- and 130-fold enrichment of WT Rif1 pro-
tein, respectively (Figure 4A). In contrast, both Rif1*RBM and
Rif1*CTD proteins showed more than 100-fold reduced telomere
localization (Figure 4A). We note that a Rif1*RBM/CTD double
mutant has telomere occupancy similar to the single mutants
(Figure 4A), indicative of a possible background level of Rif1
binding.
ChIP analysis of WT Rif2 at telomeres revealed a 7- and
10-fold enrichment on chromosomes VI-R and XV-L, respec-
tively (Figure 4B). We observed that Rif2*RBM and Rif2*AAA+
mutants reproducibly showed reduced binding to about 50%
and 30% of that seen in the RIF2 WT strain, and a slight addi-
tional decrease was observed in a strain expressing the
Rif2*RBM/AAA+ double mutant protein, perhaps to background
levels (Figure 4B). These in vivo results are particularly remark-
able for Rif1*CTD, which showed a clear defect in tetramerization,
and Rif1CTD exhibited weaker Rap1 binding than Rif1RBM in vitro.
Given that Rif1*CTD does not aggregate in vitro (Figure S3B) and
is expressed at WT levels in cells (Figure S5B), the Rif1*CTD
phenotype is a consequence of impaired Rap1 binding due to
defects in tetramerization. In conclusion, all Rap1-binding inter-
faces in Rif1 (RBM and CTD) and Rif2 (RBM and AAA+) are func-
tional in vivo, where they are required for efficient recruitment of
Rif1 and Rif2 to telomeres.
Rap1-Binding Modules in Rif1-Rif2 Are Required for
Wild-Type Telomere Length Regulation
Next, we tested whether decreased Rif1 or Rif2 telomere occu-
pancy, due to mutation of the multivalent long-range Rap1-
binding modules, was sufficient to elicit a biological response
strong enough to interfere with telomere homeostasis. Rif1 and
Rif2 negatively regulate telomere length in a telomerase-
dependent manner (Hardy et al., 1992; Levy and Blackburn,
2004; Wotton and Shore, 1997). Deletion of RIF1 gives rise to
an approximate 300 bp increase in average telomere TG tract
length (Figure 4C) (Hardy et al., 1992). Whereas telomere elonga-
tion for rif1*RBM and rif1*CTD was pronounced (150 bp), the
phenotypes did not correspond to that of a full RIF1 deletion
(Figure 4C). A Rif1 mutant strain lacking its entire Rap1 binding
C terminus (rif1_DC) also gave rise to an intermediate telomere
length phenotype, very similar to that seen for the rif1*RBM single
mutant (Figure S5D).
Loss of RIF2 also results in a telomere elongation phenotype,
though one that is less pronounced than that seen for the loss of
RIF1 (Wotton and Shore, 1997). We found that rif2*RBM and
rif2*AAA+ strains had non-WT telomeres with TG tract length
increases of 50 bp in comparison to the WT strain (Figure 4D).In conclusion, rif1*RBM, rif1*CTD, rif2*RBM, and rif2*AAA+, defective
in Rap1 binding and telomere localization, also show defects in
telomere length regulation.
Rap1-Binding Modules in Rif1-Rif2 Are Required for
Antagonizing SIR-Mediated Silencing
The Rif1 and Rif2 capping complex antagonizes transcriptional
silencing of genes placed in the vicinity of telomeres, also known
as telomere position effect (TPE) (Wotton and Shore, 1997;
Gottschling et al., 1990; Kyrion et al., 1993). Telomeric silencing
utilizes most of the genes (SIR2, SIR3, and SIR4) required for
silencing of the HM loci (Aparicio et al., 1991). Deletion of RIF1,
and to a lesser extent RIF2, triggers increased telomeric
silencing (Wotton and Shore, 1997), presumably because Sir
and Rif proteins compete for binding to the Rap1RCT domain at
telomeres. This notion of competitive interplay between Sir and
Rif proteins at telomeres is strongly supported by earlier Y2H
analysis (Wotton and Shore, 1997), although the detailed molec-
ular basis of this effect is currently unknown.
Using X-ray crystallography, Chen et al., 2011 previously
observed that a Sir3 peptide (Sir3RBM) binds the Rap1RCT
domain. Now, our results show that the Rap1-binding motifs in
Sir3, Rif1, and Rif2 occupy the same binding groove on Rap1
(Figure 4E). On the basis of structural superposition, Sir3RBM,
Rif1RBM, and Rif2RBM within this Rap1 RBM-binding groove are
fully overlapping and, hence, mutually exclusive (Figures
4F–4G). Surprisingly, the secondary structure motifs of the
RBM domains used for Rap1 binding differ, as does the direc-
tionality of the protein chains, revealing an unexpected structural
plasticity. This was not anticipated on the basis of sequence
analysis and precluded prior recognition of Rif1 and Rif2 RBM
motifs (see Figure S5H–S5I).
To ask whether the Rif1 and Rif2 scaffold competes through
its RBM domains with Sir3 for binding Rap1 in vivo, we used
standard reporter genes placed at a truncated telomere (telVII-
L::URA3) (Figure 4H, see Extended Experimental Procedures
for a detailed description). The rif1*RBM mutant strain was found
to exhibit a 100-fold increase in URA3 repression (as measured
by the fluoroorotic acid [FOA] growth assay), an effect similar to
that seen in a rif1D strain, and indicative of increased Sir3
activity at the locus. Similarly, mutations in the RBM motif of
Rif2 (rif2*RBM) gave rise to a TPE phenotype comparable to
that of rif2D cells. The rif1*RBM/rif2*RBM double mutant showed
a greater than additive increase in URA3 repression (103-
fold), indicating that the RBM domains of Rif1 and Rif2 synergis-
tically antagonize telomeric silencing. We note that the TPE
effects of rif1*RBM and rif2*RBM cannot be explained by an indi-
rect effect acting through telomere length, given that, in other-
wise WT cells, an increase of >600 bp is required to affect
TPE (Kyrion et al., 1993), whereas the length change in all
mutants is considerably smaller (rif1*RBM, 150 bp; rif2*RBM,
50 bp; rif1*RBM/ rif2*RBM, 200–300 bp) (Figures 4C–4D and
S5E). Thus, the Rif1RBM and Rif2RBM motifs are required to
antagonize silencing and function synergistically in competing
with Sir3 for the Rap1-binding groove in vivo.
Next, we asked if modulating silencing requires only the RBM
domains or whether all Rap1-binding interfaces in Rif1 and Rif2
are needed for competition with SIR proteins. We focused onCell 153, 1340–1353, June 6, 2013 ª2013 Elsevier Inc. 1347
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Figure 4. Functional Analysis of Rap1-Binding Modules in Rif1 and Rif2 In Vivo
(A and B) Rif1 and Rif2mutants defective in Rap1 binding do not accumulate at native telomeres. Cells expressingMyc-taggedWTRif1 or Rif1 mutant proteins (A)
or those expressing WT Rif2 or Rif2 mutant proteins (B) (mutations listed in Figure S5A) were chromatin immunoprecipitated and analyzed for telomeres Tel VI-R
and Tel XV-L. Results are reported as average fold enrichment relative to the PDI1 control gene (see Experimental Procedures). Detailed values are provided in
Figure S5F, and data are represented as mean ± SD.
(C and D) Rif1 and Rif2 mutations that compromise Rap1 binding cause elongated telomeres. Genomic DNA was isolated from rif1 (C) and rif2 (D) mutant strains,
digested with XhoI, and subjected to southern blotting with a telomeric TG1-3 repeat probe.
(E) Superposition of the Rif1RBM (cyan)-Rap1RCT (yellow), Rif2RBM (red)-Rap1RCT, and Sir3RBM (gray)-Rap1RCT structures illustrating that the binding of the three
peptides to the Rap1 RBM groove is expected to be mutually exclusive because of steric clashes. Sir3RBM binds in reverse orientation with respect to Rif1RBM
and Rif2RBM.
(legend continued on next page)
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Rif1, which had the most pronounced effects on silencing
(Figure 4H) (Wotton and Shore, 1997; Feeser and Wolberger,
2008). Silencing assays at telomeres revealed a comparable
magnitude of silencing effects for rif1*CTD and rif1*RBM mutant
strains (Figure 4I). This observation correlates with the similar
decrease of Rif1*CTD and Rif1*RBM mutant proteins in their
telomere occupancies, as measured by ChIP (Figure 4A). Thus,
silencing changes in rif1 mutants are primarily caused by
reduced Rif1 telomere occupancy because of an impaired
Rap1 interaction. Furthermore, we conclude that all Rap1-
binding domains tested in Rif1 (Rif1RBM and Rif1CTD) and Rif2
(Rif2RBM) are simultaneously needed for modulating telomeric
silencing in vivo.
Mutations of Rap1-Binding Interfaces in Rif2, but Not in
Rif1, Trigger the G2/M Checkpoint at Telomeric DSBs
Defects in replication, repair, or telomere capping trigger a G2/
M checkpoint arrest (reviewed in Lisby and Rothstein, 2004).
We used a single-cell assay to assess the role of the Rif1
and Rif2 scaffold in inhibiting the G2/M checkpoint activation
triggered by an HO-endonuclease-induced DSB flanked by
80 bp telomere tracts (TG80) (Michelson et al., 2005). WT
Rif1 and Rif2 are required for the prevention of short TG80
telomeric tracts from initiating a DNA-damage response that
arrests the cell cycle, each deletion mutant giving rise to a
transient G2/M delay of about 1 hr after HO-induced cleavage
(Ribeyre and Shore, 2012). Using our Rif1 and Rif2 mutants,
we found that rif2*AAA+ caused a G2/M arrest (1 hr) com-
parable to that seen in the rif2D strain (Figure 5A), whereas
mutations in the Rif2RBM domain (rif2*RBM) led to a slightly
shorter arrest of 30–45 min (Figure 5A). Thus, both long-range
Rif2RBM and Rif2AAA+ interfaces, used for Rap1 binding and
telomere recruitment, are needed for the prevention of inap-
propriate G2/M checkpoint activation at short telomeres
in vivo.
When testing the Rif1 mutants in the G2/M assay, we found
that the single rif1*RBM or rif1*CTD mutant strains did not signif-
icantly delay cell-cycle progression (Figure 5B), although rif1D
did. This was observed despite the fact that the Rif1*CTD and
Rif1*RBM mutant proteins appear to be practically absent at
normal, undamaged telomeres and display clear phenotypes
in telomere length regulation and transcriptional silencing.
Thus, we examined in detail whether Rif1*RBM or Rif1*CTD
mutant proteins are recruited to telomeric DSBs despite their
compromised Rap1 binding. Before HO-mediated DSB forma-
tion at the duplicated TG80 arrays, WT Rif1 is clearly detect-
able, whereas Rif1*RBM or Rif1*CTD binding appears consider-(F) Structure-based sequence alignment of the RBMmotifs in Rif1, Rif2, and Sir3.
Rif2RBM, and Sir3RBM involved in Rap1 binding are highlighted in red.
(G) Stick representations of residues from Rif1RBM, Rif2RBM, and Sir3RBM that inte
indicated in rainbow coloring from red for N termini to green for C termini.
(H) Rif1 and Rif2 compete with Sir3 for the Rap1 RBM-binding groove in vivo. Tel
and yeast strains are listed in Table S2). Growth on medium containing 5-FOA ind
mutants give rise to silencing phenotypes similar to those seen after the deletion
(I) Mutation of any of Rap1-binding interfaces (Rif1RBM or Rif1CTD) in Rif1 sim
with rif1*RBM, rif1*CTD or rif1 deletion strains.
See also Figure S5 and Table S2.ably lower (Figure 5C). The reduced presence of Rif1*RBM and
Rif1*CTD is in line with our observation of decreased recruitment
of these mutants to native telomeres (Figure 4A). Following HO
cutting, additional WT Rif1 is recruited to both TG80 ends,
perhaps partly because they are actively elongated. Surpris-
ingly, Rif1*RBM and Rif1*CTD were also readily detectable at
the HO-cut TG80 ends (Figure 5C), albeit at lower levels in
comparison to the Rif1 WT protein. The fold increase of WT
Rif1 and Rif1*RBM (or Rif1*CTD) at the TG80 tracts before and
after HO induction was comparable (5-fold). A Rif1*RBM/CTD
double mutant, expected to be further compromised in Rap1
binding, was, nonetheless, recruited to the TG80 ends and
showed a WT G2/M checkpoint response, (Figures 5B and
5C). Although they are defective in telomere binding, length
regulation, and silencing, the rif1*RBM and rif1*CTD mutant
strains exhibit a separation-of-function phenotype with respect
to their G2/M checkpoint role allowing for Rap1-independent
recruitment to telomeric DSBs (see Figures S6A–S6B for further
characterization and discussion of Rif1 G2/M separation of
function).
In summary, we have observed that Rif1 and Rif2 bestow
specific binding of Rap1 to arrays of Rap1 binding sites in vitro
in a manner dependent on the Rif1 and Rif2 multivalent long-
range Rap1-binding interactions identified by structural means.
We found that these multivalent interactions are all required for
Rif1 and Rif2 telomere binding and modulating telomeric
silencing in vivo. In the case of Rif1, defects in the long-range
Rap1-binding modules had no discernable effect on Rif1-
mediated G2/M checkpoint inhibition, although other pheno-
types related to telomere length regulation and silencing were
detected.
DISCUSSION
Model for Rap1-Rif1-Rif2 Assembly at Telomeric Arrays
The structural and biochemical findings reported here allow us to
define the principal structural building blocks of the higher-order
telosome assembly at double-stranded Rap1-binding site
repeats.
Rap1-Rif2: Interconnecting Neighboring Rap1 Units
Rif2 can bind individual Rap1 molecules either through its AAA+
or RBM interfaces, both of which have comparable affinity.
When neighboring Rap1 molecules are spaced in close prox-
imity, Rif2 is expected to be able to interconnect two Rap1 mol-
ecules in trans using both interfaces connected through a flex-
ible linker. A hypothetical model of such an assembly,
assuming Rap1-binding sites are set apart by 19 bp, is shownHelices are denoted as cylinders. Equivalent hydrophobic residues in Rif1RBM,
ract with Rap1RCT (shown in cartoon representation). RBM peptide polarity is
omeric silencing was assayed with a telVII::URA3 reporter (relevant genotypes
icates increased telomeric silencing. rif1*RBM, rif2*RBM or rif1*RBM, and rif2*RBM
of RIF1, RIF2 or RIF1, and RIF2, respectively.
ilarly affect telomeric silencing. Silencing assays were performed as in (H)
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Figure 5. Influence of Rif1 and Rif2 Mutants on G2/M Arrest at
Telomeric DSBs
(A) Mutations of the Rap1-binding interfaces in Rif2 result in inadvertent
checkpoint activation. Short (80 bp) telomeric tracts flanking an HO-
1350 Cell 153, 1340–1353, June 6, 2013 ª2013 Elsevier Inc.in Figure 6A. Because of the length restriction of the Rif2 flexible
linker connecting the RBM and AAA+ domains (spanning a
maximal length of 42 A˚), Rif2-Rap1 trans binding is expected
to be dependent on the DNA spacing and the radial orientation
between Rap1-binding sites. The system is most likely expected
to be plastic, given that Rap1RCT is connected to the remainder
of Rap1 through a flexible linker (70 A˚ to maximally 90 A˚ in
length) and Rap1 binding may induce distortion of the DNA (Gil-
son et al., 1993).
Rap1-Rif1: Interconnecting Distal Rap1 Units
The Rif1RBM epitope is attached to its Rif1CTD domain via
a 110 A˚ linker. Although Rif1RBM appears to be the major
Rap1-binding site in our in vitro assay, Rif1CTD plays only an
accessory role. However, we observed in vivo that both
the RBM and CTD domains are of equal importance in
telomere homeostasis. On the basis of molecular modeling,
we estimate that Rif1, with its four RBM domains coupled to
its tetramerization CTD domain, can interlink up to four neigh-
boring Rap1 units over 30 bp of spacing between Rap1-
binding sites (Figure 6B). Thus, the Rif1RBM tetramer with its
predicted end-to-end distance of 2 3 110 A˚ is expected to
bridge Rap1 molecules over longer distances in comparison
to Rif2.
Mixed Rap1-Rif1 and Rap1-Rif2 Interconnections
Although the Rif1RBM and Rif2RBM interfaces on Rap1 are directly
overlapping, the Rif1RBM or Rif2RBM interfaces are not mutually
exclusive with those of Rif2AAA+ and Rif1CTD (structural studies
Figures 1, 2, and 3A and mutagenesis by Feeser and Wolberger,
2008). This allows Rap1, once its RBM-binding groove is
occupied by either Rif1 or Rif2, to bind neighboring Rif2 or Rif1
molecules through the AAA+ or CTD interfaces, respectively
(Figure 6C).
The Velcro Model for Telomere Organization
Now, we provide the biochemical, biophysical, and structural
characterization of Rap1, Rif1, and Rif2 binding to telomeric
arrays. In vitro, a higher-order interlinked scaffold exists
when reconstituting Rap1, Rif1, and Rif2 on a native telomeric
DNA substrate (Figures 3B and 3C). Such interlinking also ap-
pears to operate in vivo. The Rif1 RBM domain is the main
Rap1-binding site, although the CTD domain has a lower
Rap1 affinity, providing trans binding through tetramerization.
However, in vivo, neither one alone suffices as a Rap1-bindingendonuclease-inducible DNA double-strand break (DSB) on both sites. The
percentage of large-budded (G2/M-arrested) cells after HO cleavage in the
indicated strains (mutations are shown in Figure S5A) is plotted against time,
indicating cell-cycle progression. The average restart time for each strain
(indicated in parentheses along with the number of measured cells) was esti-
mated with a Kaplan-Meier survival analysis (see also Table 1).
(B) Mutations of Rap1-binding interfaces in Rif1 do not activate an inadvertent
checkpoint response. G2/M arrest assays were performed as in (A) with the
indicated strains (Rif1 mutations are shown in Figure S5A) or a rif1 deletion
strain (listed in Table S2).
(C) Rif1 mutant proteins are recruited to telomeric DSBs. Cells expressing
Myc-tagged WT Rif1 or Rif1 mutant proteins were analyzed by ChIP before
and after HO cleavage at TG80 telomeric tracts. Calculations were performed
as in Figure 4A, and values are listed in Figure S5G. Data are represented as
mean ± SD.
See also Figure S6 and Table S2.
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Figure 6. Model of the Rap1-Rif1-Rif2
Assembly at Telomeres
(A) Rif2-Rap1 binding in trans on telomeric
repeats. Three closely positioned Rap1molecules
(1 to 3, 19 bp spacing between each Rap1-
binding site) are interlinked by Rif2AAA+ and
Rif2RBM domains in trans. A cartoon color legend
is shown on the top. Rap1 is depicted with
Rap1RCT and Rap1myb, Rif1 with Rif1CTD and
Rif1RBM only. The Rap1BRCT and Rif1 N-terminal
domains are omitted for clarity.
(B) Rif1-Rap1 binding in trans on telomeric
repeats employing the tetramerization domain.
The long flexible linker bridging up to 110 A˚
between Rif1CTD and Rif1RBM allows Rif1 to
interconnect distal Rap1 molecules (Rap1-
binding sites 3 and 5 are spaced by 30 bp).
(C) Mixed Rif1-Rap1 and Rif2-Rap1 binding on
telomeric repeats. Rif2 and Rif1 are bound to the
same Rap1 through the Rif2AAA+ and the Rif1RBM
domains, respectively, resulting in a heteroge-
neous assembly.
(D) Molecular model on the basis of structures
determined herein, and the ones determined from
Ko¨nig et al., 1996; Matot et al., 2012.
See also Figure S7.module for telomere recruitment of Rif1. Similarly for Rif2, mu-
tation of either Rap1-binding site (Rif2RBM or Rif2AAA+) was
equivalent to the disruption of both sites simultaneously. Alto-
gether, this suggests that multivalent weak Rap1-binding
modules provided by Rif1 and Rif2 serve in stabilizing telo-
some formation in vivo. Furthermore, the observed Rap1 pref-Cell 153, 1340–13erence for arrays in the presence of
Rif1 and Rif2 in vitro provides a
biochemical rationale for the preferen-
tial binding of Rap1-Rif1-Rif2 to telo-
meres in vivo.
The exact spatial organization and
local concentrations of Rap1, Rif1, and
Rif2 on telomeres is unknown. On the ba-
sis of our data, we propose a model
where interactions (Figures 6A–6C) iden-
tified by structural means, characterized
in solution, and found to bestow array-
specific Rap1 binding to telomeric DNA
would predict a high propensity for
Rap1-Rif1-Rif2 to form a molecular
Velcro, in which Rap1 units become in-
terlinked in a Rif1- and Rif2-dependent
manner in vivo. Rap1 affinities provided
by Rif1RBM, Rif2RBM, and Rif2AAA+ appear
balanced (20–50 mM), in principle allow-
ing a stochastic combination of the
different possible binding modes. We
favor a model where Rap1, Rif1, and
Rif2 form a heterogeneous assembly
rather than a defined stoichiometric
complex (Figure 6D), given that this maybe better adapted to accommodate the irregular DNA spacing
found at telomeric Rap1 site arrays in budding yeast (see also
Figure S7).
The Velcro-like binding mode utilizing arrays of weak binding
sites confers plasticity to structures such as the telosome, allow-
ing them to undergo disassembly and reformation in every S53, June 6, 2013 ª2013 Elsevier Inc. 1351
Table 1. Summary of In Vivo Assays for Mutants of Rif1 and Rif2
G2/M Arrest Assay
Genotype
Average Restart
Time (hr)
Phenotype Similar to
(WT/D) Telomere Length
Silencing Deficiency
(TPE)
Controls WT 4.1 WT WT WT
rif2D 5.1 D ++ ++
Rif2AAA+-Rap1 Interface rif2-E347R 5.1 D + ND
Rif2RBM-Rap1 Interface rif2-L44R-V45E 4.7 D + ++
Controls WT 4.1 WT WT WT
rif1D 4.9 D +++ +++
Rif1RBM-Rap1 interface rif1-I1762R-I1764R 4.3 WT + +++
Rif1CTD-Rap1 interface rif1-L1905R 4.2 WT + +++
Rif1RBM/CTD-Rap1 interface rif1-I1762R-I1764R-L1905R 4.3 WT + ND
+, increase; ND, not determined.phase while providing stability in the other phases of the cell
cycle.
Higher-Order Architectures Serving a Biological
Function
The structural and functional characterization of Rif1 and Rif2
enabled us to dissect the molecular contribution of this scaffold
to telomere homeostasis. Mutations in any of the Rap1-binding
modules in Rif1 and Rif2 resulted in defects in Rif1 and Rif2 telo-
mere recruitment (Figures 4A and 4B) and, as a consequence,
defective telomere length regulation (Figures 4C and 4D). Simi-
larly, mutations in the Rif1RBM, Rif1CTD, and Rif2RBM motifs gave
rise to transcriptional silencing effects. In silencing, we find, sur-
prisingly, that the structural RBMmotifs constituting an important
part of the Velcro architecture directly and functionally compete
with Sir3 for binding to Rap1. Thus, the Velcro is not only an
array-specific recruitment mechanism but also a functional
architecture. Although it is speculative at this point, a more direct
role of theVelcro in sterically protecting telomeres fromnucleases
or regulating telomere length through limiting telomerase access
(Gallardo et al., 2011) deserves further attention in the future.
Organizing DNA Arrays
This work provides insights into how genomic arrays (telomeric
Rap1-binding sites) are packaged through array-specific com-
plexes, such as Rif1 and Rif2, into higher-order structures, which
are, in turn, required for telomere function. Genome sequences
in many organisms often contain a large number of repeated
units that bind pleiotropic transcription factors. The multivalent
long-range interaction network observed herein, and the result-
ing Velcro architecture, would allow dedicated protein
complexes to bring novel biological functions specifically to
these repeated DNA domains.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
S. cerevisiaeRap1 and Rif1 constructs were expressed in Escherichia coli, and
full-length Rif2 was produced in insect cells. Expression and purification
procedures are outlined in the Extended Experimental Procedures.1352 Cell 153, 1340–1353, June 6, 2013 ª2013 Elsevier Inc.Crystallization and Structure Determination
Rif2 was solved by single-wavelength anomalous dispersion. The Rif2-Rap1
complex structure was solved by molecular replacement with the Rif2 struc-
ture and that of the Rap1 C-terminal domain. The Rif1CTD was solved by ab
initio methods. Details for crystallization, data collection, structure deter-
mination, and refinement statistics are given in Table S1 and the Extended
Experimental Procedures.
Biochemical Assays
Isothermal calorimetry, DNA substrate preparation, and analysis by EMSA are
outlined in the Extended Experimental Procedures.
Cellular Assays
Y2H experiments were performed as outlined in Hardy et al., 1992, and the
telomere blots andG2/M assay performed are described in Ribeyre and Shore,
2012. For experimental details and the design of silencing assays, please refer
to the Extended Experimental Procedures.ACCESSION NUMBERS
The models and structure factors have been deposited in the Protein
Data Bank with the PDB under accession numbers 4BJ1 (Rif266-380), 4BJ5
(Rif21-395-Rap1RCT), 4BJ6 (Rif235-395), 4BJT (Rif1RBM-Rap1RCT), and 4BJS
(Rif1CTD).SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and three tables and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2013.05.007.
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